COMMUNIQUÉS West-GlobeNewswire
-
ImvivaBio Presents Longer-Term Data from Clinical Studies of CTA313 Allogeneic CAR-T Therapy in Lupus at the American College of Rheumatology Convergence 2026
11/11/2026 -
aTyr Pharma to Participate in Upcoming Investor Conferences
11/11/2026 -
Five Presentations, One Leading Innovation: Humacyte’s Acellular Tissue Engineered Vessel Takes Center Stage at VEITH 2026
11/11/2026 -
Beacon Therapeutics to Participate in Jefferies 2026 Global Healthcare Conference in London
11/11/2026 -
Filana Therapeutics Names Biopharma Executive Jill M. Quigley to Board
11/11/2026 -
BioAge Labs to Present at Upcoming Investor Conferences
11/11/2026 -
LightSolver to Unveil the First Public Demonstration of its All-Optical Computer at SC26
11/11/2026 -
Boston Concierge Orthopedics Launches New Website Highlighting Shoulder and Knee Care
11/11/2026 -
MiNK Therapeutics Reports Third Quarter 2026 Results, First Pre-Commercial Product Revenue from agenT-797, Randomized ARDS Trial Advancing, and ARPA-H Selection for Deployable Cell Therapies
11/11/2026 -
Dyne Therapeutics to Participate in Upcoming Investor Conference
11/11/2026 -
PolyPid Provides Corporate Update and Reports Third Quarter 2026 Financial Results
11/11/2026 -
BridgeBio to Present New Acoramidis Data on Kidney Function, Real-World Outcomes, and First-Line Treatment Patterns in ATTR-CM at the International Symposium on Amyloidosis 2026
11/11/2026 -
Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
11/11/2026 -
Teva Shares Innovative Pipeline Updates and Unveils Path to Future Growth at R&D Day, Targeting $6–7 Billion in Innovative Medicines Revenue by 2030
11/11/2026 -
Applied Biologics Announces Research Collaboration with Dartmouth College Focused on Computational Protein Engineering
11/11/2026 -
Nkarta Presents Initial Safety Data for NKX019 in 40 Patients Across Five Autoimmune Diseases at ACR Convergence 2026
11/11/2026 -
CDT Commences Human Skin Studies with QIMA Life Sciences on Novel Tapinarof Combinations in Vitiligo
11/11/2026 -
AC Immune to Present at Jefferies Global Healthcare Conference 2026
11/11/2026 -
Horizon Europe-funded HERMOD project launches to support Phase 2 development of HER-096 in Parkinson’s disease
11/11/2026
Pages